Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mu Hao, Li Zhang, Gang An, Hengxing Meng, Youjin Han, Zhenqing Xie, Yan Xu, Changhong Li, Zhen Yu, Hong Chang & Lugui Qiu. (2011) Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression. Leukemia & Lymphoma 52:9, pages 1787-1794.
Read now
Read now
Hong Chang, Allan Jiang, Connie Qi, Young Trieu, Christine Chen & Donna Reece. (2010) Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone. Leukemia & Lymphoma 51:11, pages 2084-2091.
Read now
Read now
Morie A. Gertz. (2007) Relevant prognostic features of multiple myeloma and the new International Staging System. Leukemia & Lymphoma 48:3, pages 458-468.
Read now
Read now
Jonathan J. Keats, Tony Reiman, Andrew R. Belch & Linda M. Pilarski. (2006) Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma. Leukemia & Lymphoma 47:11, pages 2289-2300.
Read now
Read now
Hong Chang, Sara Samiee & Qi Long Yi. (2006) Prognostic relevance of CD56 expression in multiple myeloma: A study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant. Leukemia & Lymphoma 47:1, pages 43-47.
Read now
Read now
Articles from other publishers (25)
Pratibha Kadam Amare, Shraddha Nikalje Khasnis, Pranita Hande, Hrushikesh Lele, Nishigandha Wable, Snehal Kaskar, Nikita Nikam Gujar, Nilesh Gardi, Aniket Prabhudesai, Karishma Todi, Rohit Waghole & Pritha Roy. (2022) Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations. Cytogenetic and Genome Research 162:10, pages 529-540.
Crossref
Crossref
佳敏 华. (2019) Study on Clinical Diagnosis Value by Combination of Fluorescence in Situ Hybridization and Conventional Cytogenetic Analysis in Multiple Myeloma. World Journal of Cancer Research 09:01, pages 21-26.
Crossref
Crossref
Yangli Xie, Siru Zhou, Hangang Chen, Xiaolan Du & Lin Chen. (2014) RECENT RESEARCH ON THE GROWTH PLATE: Advances in fibroblast growth factor signaling in growth plate development and disorders. Journal of Molecular Endocrinology 53:1, pages T11-T34.
Crossref
Crossref
S Kasar, C Underbayev, Y Yuan, M Hanlon, S Aly, H Khan, V Chang, M Batish, T Gavrilova, F Badiane, H Degheidy, G Marti & E Raveche. (2013) Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia. Oncogene 33:25, pages 3307-3315.
Crossref
Crossref
Xiao Gao, Chunming Li, Run Zhang, Ruifang Yang, Xiaoyan Qu, Hairong Qiu, Jiaren Xu, Hua Lu, Jianyong Li & Lijuan Chen. (2011) Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma. Medical Oncology 29:3, pages 2200-2206.
Crossref
Crossref
Mei-Hsi Chen, Connie X.Y. Qi, Manujendra N. Saha & Hong Chang. (2012) p53 Nuclear Expression Correlates With Hemizygous TP53 Deletion and Predicts an Adverse Outcome for Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide. American Journal of Clinical Pathology 137:2, pages 208-212.
Crossref
Crossref
Hong Chang, Young Trieu, Xiaoying Qi, Nan N. Jiang, Wei Xu & Donna Reece. (2011) Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains. Leukemia Research 35:1, pages 95-98.
Crossref
Crossref
Johann Micallef, Moyez Dharsee, Jian Chen, Suzanne Ackloo, Ken Evans, Luqui Qiu & Hong Chang. (2010) Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma. Journal of Hematology & Oncology 3:1.
Crossref
Crossref
Michele Roullet & Adam Bagg. (2010) The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas. Advances in Anatomic Pathology 17:5, pages 333-358.
Crossref
Crossref
Marilu Nelson, Sherrie L. Perkins, Bhavana J. Dave, Peter F. Coccia, Julia A. Bridge, Elizabeth R. Lyden, Nyla A. Heerema, Mark A. Lones, Lauren Harrison, Mitchell S. Cairo & Warren G. Sanger. (2010)
An increased frequency of 13q deletions detected by fluorescence
in situ
hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG-5961
. British Journal of Haematology 148:4, pages 600-610.
Crossref
Crossref
Donna ReeceKevin W. SongTommy FuBirgitte RolandHong ChangDouglas E. HorsmanAdnan MansoorChristine ChenEsther Masih-KhanYoung TrieuHelene Bruyere, Douglas A. Stewart & Nizar J. Bahlis. (2009) Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13. Blood 114:3, pages 522-525.
Crossref
Crossref
W. XU, J.-Y. LI, L. FAN, L.-J. CHEN, H.-R. QIU, H.-X. QIU & H. LU. (2009) Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia. International Journal of Laboratory Hematology 31:3, pages 338-343.
Crossref
Crossref
Sung-Hyun KimJung Hwan KimDong Mee LeeSuee LeeSung Yong OhHyuk-Chan KwonKyung-Eun KimJin-Yeong HanHyo-Jin Kim. (2009) Comparison between Conventional Cytogenetics and Interphase Fluorescence in situ Hybridization (FISH) for Patients with Multiple Myeloma. The Korean Journal of Hematology 44:1, pages 14.
Crossref
Crossref
YA-PING CHEN, YU-SHAN YEN, TSAI-YUN CHEN, CHIA-LIANG YEN, CHI-CHANG SHIEH & KUNG-CHAO CHANG. (2008)
Systemic
Mycobacterium kansasii
infection mimicking peripheral T-cell lymphoma
. APMIS 116:9, pages 850-858.
Crossref
Crossref
Ji Won LeeJin Kyung LeeYoung Joon HongSeok-Il HongYoon Hwan Chang. (2008) Correlation of Chromosomal Aberrations with Prognostic Markers in Multiple Myeloma Patients- A Single Institution Study. The Korean Journal of Laboratory Medicine 28:6, pages 413.
Crossref
Crossref
Laurens Nieuwenhuizen & Douwe H. Biesma. (2007) Central nervous system myelomatosis: review of the literature. European Journal of Haematology 0:0, pages 071026234508002-???.
Crossref
Crossref
Hong Chang, Young Trieu, Xiaoying Qi, Wei Xu, Keith A. Stewart & Donna Reece. (2007) Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma. Leukemia Research 31:6, pages 779-782.
Crossref
Crossref
C. Sreekantaiah. (2007) FISH panels for hematologic malignancies. Cytogenetic and Genome Research 118:2-4, pages 284-296.
Crossref
Crossref
Jinfen Wang, Lillian Young, William Win & Clive R Taylor. (2005) Distribution and ZAP-70 Expression of WHO Lymphoma Categories in Shanxi, China. Applied Immunohistochemistry & Molecular Morphology 13:4, pages 323-332.
Crossref
Crossref
H Chang, X Y Qi, S Samiee, Q-L Yi, C Chen, S Trudel, J Mikhael, D Reece & A K Stewart. (2005) Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation. Bone Marrow Transplantation 36:9, pages 793-796.
Crossref
Crossref
Ming-Yuan Lee, Mei-Hua Tsou, Tran-Der Tan & Mei-Chun Lu. (2005) Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma. European Journal of Haematology 75:3, pages 221-226.
Crossref
Crossref
H Chang, X Y Qi & A K Stewart. (2005) t(11;14) does not predict long-term survival in myeloma. Leukemia 19:6, pages 1078-1079.
Crossref
Crossref
Hong ChangConnie QiQi-Long YiDonna ReeceA. Keith Stewart. (2005) p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation. Blood 105:1, pages 358-360.
Crossref
Crossref
Hong Chang, Stephen Sloan, Dan Li & Bruce Patterson. (2005) Genomic aberrations in plasma cell leukemia shown by interphase fluorescence in situ hybridization. Cancer Genetics and Cytogenetics 156:2, pages 150-153.
Crossref
Crossref
Hong Chang, Stephen Sloan, Dan Li & A. Keith Stewart. (2004) Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions. British Journal of Haematology 127:3, pages 280-284.
Crossref
Crossref